Grade My Investments
HomeFree Stock Grades › CTEV

Claritev Corporation (CTEV) Stock Grade

CTEV · Healthcare

A+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$702.6M
P/E Ratio
Revenue Growth (YoY)
+3.7%
Net Margin
-29.5%
Return on Equity
163.5%
Dividend Yield
None

About Claritev Corporation's fundamentals

Claritev Corporation is a healthcare information services company with a market capitalization of $702.6 million that reported modest revenue growth of 3.7% year-over-year. However, the company is currently unprofitable, posting a net margin of -29.5% in its latest annual statement, which explains why a P/E ratio cannot be calculated. The unusually high return on equity of 163.5% reflects the company's negative net income relative to shareholder equity rather than operational strength. The company does not pay a dividend, with all capital presumably directed toward operations and growth initiatives.

Track CTEV free — no credit card required. Live grade + monthly AI report →